67.29
Overview
News
Price History
Option Chain
Financials
Why CVS Down?
Discussions
Forecast
Stock Split
Dividend History
Cvs Health Corp stock is traded at $67.29, with a volume of 16.05M.
It is down -1.84% in the last 24 hours and up +0.96% over the past month.
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It also operates a top-tier health insurer (acquired through Aetna) where it serves about 27 million medical members. The company's recent acquisition of Oak Street adds primary care services to the mix, which could have significant synergies with all existing business lines.
See More
Previous Close:
$68.55
Open:
$65.42
24h Volume:
16.05M
Relative Volume:
1.54
Market Cap:
$87.36B
Revenue:
$372.81B
Net Income/Loss:
$4.61B
P/E Ratio:
18.39
EPS:
3.66
Net Cash Flow:
$6.33B
1W Performance:
-2.44%
1M Performance:
+0.96%
6M Performance:
+5.69%
1Y Performance:
-1.91%
Cvs Health Corp Stock (CVS) Company Profile
Name
Cvs Health Corp
Sector
Industry
Phone
(401) 765-1500
Address
ONE CVS DR., WOONSOCKET
Compare CVS with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
CVS
Cvs Health Corp
|
67.29 | 87.36B | 372.81B | 4.61B | 6.33B | 3.66 |
![]()
UNH
Unitedhealth Group Inc
|
454.11 | 536.99B | 400.28B | 14.41B | 20.71B | 15.50 |
![]()
ELV
Elevance Health Inc
|
424.53 | 99.88B | 176.81B | 5.98B | 4.55B | 25.61 |
![]()
CI
Cigna Group
|
330.13 | 89.25B | 244.38B | 3.43B | 8.96B | 12.24 |
![]()
HUM
Humana Inc
|
264.48 | 34.38B | 117.76B | 1.21B | 2.39B | 9.95 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Feb-13-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
Feb-12-25 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
Jan-30-25 | Upgrade | Edward Jones | Hold → Buy |
Dec-03-24 | Upgrade | Deutsche Bank | Hold → Buy |
Nov-18-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
Oct-10-24 | Upgrade | Barclays | Equal Weight → Overweight |
Oct-04-24 | Upgrade | TD Cowen | Hold → Buy |
May-30-24 | Initiated | Robert W. Baird | Neutral |
May-07-24 | Downgrade | TD Cowen | Buy → Hold |
May-02-24 | Downgrade | UBS | Buy → Neutral |
May-01-24 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
May-01-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
Mar-06-24 | Initiated | Barclays | Equal Weight |
Feb-26-24 | Initiated | Leerink Partners | Outperform |
Dec-22-23 | Initiated | HSBC Securities | Buy |
Sep-19-23 | Upgrade | Evercore ISI | In-line → Outperform |
Sep-12-23 | Upgrade | Wolfe Research | Peer Perform → Outperform |
Aug-18-23 | Downgrade | Edward Jones | Buy → Hold |
May-26-23 | Initiated | Piper Sandler | Overweight |
Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
Nov-23-22 | Resumed | Morgan Stanley | Overweight |
Jun-17-22 | Initiated | Loop Capital | Buy |
May-27-22 | Downgrade | Bernstein | Outperform → Mkt Perform |
Mar-29-22 | Downgrade | Deutsche Bank | Buy → Hold |
Feb-11-22 | Downgrade | Raymond James | Strong Buy → Outperform |
Dec-14-21 | Initiated | Goldman | Buy |
Dec-01-21 | Initiated | Seaport Research Partners | Buy |
May-19-21 | Initiated | Wells Fargo | Equal Weight |
Mar-17-21 | Downgrade | Guggenheim | Buy → Neutral |
Jan-08-21 | Upgrade | Jefferies | Hold → Buy |
Sep-17-20 | Initiated | Piper Sandler | Overweight |
Jul-01-20 | Initiated | SVB Leerink | Mkt Perform |
May-14-20 | Upgrade | Credit Suisse | Neutral → Outperform |
Sep-27-19 | Resumed | RBC Capital Mkts | Outperform |
Sep-12-19 | Initiated | Deutsche Bank | Buy |
Jun-05-19 | Upgrade | Standpoint Research | Hold → Buy |
Apr-29-19 | Downgrade | Credit Suisse | Outperform → Neutral |
Apr-18-19 | Initiated | Guggenheim | Buy |
Apr-15-19 | Downgrade | Oppenheimer | Outperform → Perform |
Apr-10-19 | Reiterated | BofA/Merrill | Buy |
Mar-13-19 | Initiated | Bernstein | Outperform |
Feb-20-19 | Downgrade | Wells Fargo | Outperform → Market Perform |
Jan-17-19 | Initiated | UBS | Buy |
Dec-18-18 | Initiated | Barclays | Overweight |
Nov-29-18 | Resumed | Goldman | Neutral |
Nov-28-18 | Initiated | Evercore ISI | Outperform |
Oct-26-18 | Resumed | Wolfe Research | Peer Perform |
Jul-09-18 | Upgrade | Citigroup | Neutral → Buy |
Feb-27-18 | Resumed | BofA/Merrill | Buy |
Feb-13-18 | Reiterated | Citigroup | Neutral |
View All
Cvs Health Corp Stock (CVS) Latest News
CVS Health (NYSE:CVS) Shares Gap DownShould You Sell? - MarketBeat
CVS Health Co. (NYSE:CVS) Shares Sold by Bridgewater Associates LP - MarketBeat
Gamco Investors INC. ET AL Decreases Stock Position in CVS Health Co. (NYSE:CVS) - MarketBeat
Sagespring Wealth Partners LLC Purchases New Position in CVS Health Co. (NYSE:CVS) - MarketBeat
Synovus Financial Corp Trims Stake in CVS Health Co. (NYSE:CVS) - MarketBeat
Stamos Capital Partners L.P. Buys 9,000 Shares of CVS Health Co. (NYSE:CVS) - MarketBeat
Advisors Capital Management LLC Grows Position in CVS Health Co. (NYSE:CVS) - MarketBeat
6,467 Shares in CVS Health Co. (NYSE:CVS) Bought by Carson Advisory Inc. - MarketBeat
CVS Health Co. (NYSE:CVS) Shares Sold by Townsquare Capital LLC - MarketBeat
Jim Cramer Defended American Superiority and Discussed These 13 Stocks - Insider Monkey
FIL Ltd Buys 7,143 Shares of CVS Health Co. (NYSE:CVS) - MarketBeat
Jim Cramer on CVS Health Corporation (CVS): The Last Drugstore Standing - MSN
Gabelli Funds LLC Sells 26,050 Shares of CVS Health Co. (NYSE:CVS) - MarketBeat
Guggenheim Capital LLC Sells 13,185 Shares of CVS Health Co. (NYSE:CVS) - MarketBeat
Optimize Financial Inc Buys Shares of 8,158 CVS Health Co. (NYSE:CVS) - MarketBeat
Noteworthy Thursday Option Activity: DG, CRWD, CVS - Nasdaq
CVS, Humana and Elevance Shares Are Trading Lower Thursday: What's Going On? - Benzinga
CVS Health (CVS) to Close Pharmacies in Arkansas Following New Law - GuruFocus
CVS Health to close over 20 stores in Arkansas after PBM law - Seeking Alpha
Robert W. Baird Forecasts Strong Price Appreciation for CVS Health (NYSE:CVS) Stock - MarketBeat
CVS Health Co. (NYSE:CVS) Position Boosted by Dodge & Cox - MarketBeat
Jump Financial LLC Purchases 332,903 Shares of CVS Health Co. (NYSE:CVS) - MarketBeat
M Holdings Securities Inc. Acquires Shares of 10,891 CVS Health Co. (NYSE:CVS) - MarketBeat
16,913 Shares in CVS Health Co. (NYSE:CVS) Purchased by Canada Post Corp Registered Pension Plan - MarketBeat
Rockefeller Capital Management L.P. Sells 179,651 Shares of CVS Health Co. (NYSE:CVS) - MarketBeat
Inlight Wealth Management LLC Takes $2.17 Million Position in CVS Health Co. (NYSE:CVS) - MarketBeat
CVS Health Co. (NYSE:CVS) Stock Position Reduced by Ceeto Capital Group LLC - MarketBeat
Arkansas bans pharmacy benefit managers from owning pharmacies in state - Value The Markets
CVS Health (CVS) Stock Moves -0.55%: What You Should Know - Yahoo Finance
CVS Health Co. (NYSE:CVS) Shares Sold by Value Partners Investments Inc. - MarketBeat
CVS Health Co. (NYSE:CVS) Shares Sold by Argent Trust Co - MarketBeat
Heritage Trust Co Buys New Holdings in CVS Health Co. (NYSE:CVS) - MarketBeat
CVS Health vs. UnitedHealth: Which Healthcare Stock Has More Upside? - Yahoo Finance
Morgan Stanley Ups Price Target for CVS Health (CVS) to $80 | CVS Stock News - GuruFocus
2 Healthcare Recession-Resistant Stocks Unaffected by Tariffs - Benzinga
Bullish CVS Health Insiders Loaded Up On US$2.56m Of Stock - Yahoo Finance
CVS Health (CVS) Price Target Raised by Baird Amid Policy Uncert - GuruFocus
Envestnet Asset Management Inc. Acquires 15,561 Shares of CVS Health Co. (NYSE:CVS) - MarketBeat
Nicolet Bankshares Inc. Sells 4,183 Shares of CVS Health Co. (NYSE:CVS) - MarketBeat
Scotia Capital Inc. Trims Holdings in CVS Health Co. (NYSE:CVS) - MarketBeat
Greenland Capital Management LP Takes Position in CVS Health Co. (NYSE:CVS) - MarketBeat
CVS Health (CVS) Appoints New CFO Amid Restructuring Efforts - GuruFocus
Walgreens Comeback? Private Equity Circling for a Buyout - Benzinga
CVS Health (NYSE:CVS) Shares Gap UpStill a Buy? - MarketBeat
CVS names UPS executive Brian Newman as CFO - MSN
Executive reshuffles: CVS, NNDM, and DBX - MSN
CVS Health Stock Soars: Strategic Moves and Market Boost - TipRanks
LSV Asset Management Sells 289,490 Shares of CVS Health Co. (NYSE:CVS) - MarketBeat
Peapack Gladstone Financial Corp Sells 37,995 Shares of CVS Health Co. (NYSE:CVS) - MarketBeat
CVS Health (CVS) Benefits from Medicare Advantage Payment Increa - GuruFocus
Truist Ups Price Target for CVS Health (CVS) Amid Positive Q1 Ou - GuruFocus
Cvs Health Corp Stock (CVS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cvs Health Corp Stock (CVS) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Clark James David | SVP, Cont & Chief Acct Officer |
Mar 05 '25 |
Option Exercise |
62.21 |
7,513 |
467,384 |
15,907 |
Clark James David | SVP, Cont & Chief Acct Officer |
Mar 05 '25 |
Sale |
66.35 |
7,513 |
498,488 |
8,394 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):